PECAM1 and neoplasm: Exposure of KNS42 and U87 aggregates to either inhibitor (at doses observed not to impair cell viability in monolayer culture, see Supplementary Figure 3) resulted in complete loss of tumor-derived CD105 and CD31 expression (Figure 6), when compared to untreated cells (Figure 1D–1E and 1J).